Richard A. Sandberg, Director at Oxford Immunotec Global PLC (OXFD), sold 3,000 shares at $14.25 ($43K) on 2019-02-01, disclosed to the SEC on 2019-02-01.
Scheduled sale ($43k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRPO | BUY | 2025-05-30 | $14K | — | Filing → |
| PRPO | BUY | 2025-05-28 | $990 | — | Filing → |
| PRPO | BUY | 2025-05-27 | $5K | — | Filing → |